TG Therapeutics Inc (TGTX)
36.25
+1.18
(+3.36%)
USD |
NASDAQ |
Nov 25, 11:03
TG Therapeutics Shareholders Equity (Quarterly): 192.16M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 192.16M |
June 30, 2024 | 177.57M |
March 31, 2024 | 160.11M |
December 31, 2023 | 160.50M |
September 30, 2023 | 164.77M |
June 30, 2023 | 40.45M |
March 31, 2023 | 27.43M |
December 31, 2022 | 58.59M |
September 30, 2022 | 100.48M |
June 30, 2022 | 129.04M |
March 31, 2022 | 170.39M |
December 31, 2021 | 237.15M |
September 30, 2021 | 311.52M |
June 30, 2021 | 383.13M |
March 31, 2021 | 445.28M |
December 31, 2020 | 519.35M |
September 30, 2020 | 170.66M |
June 30, 2020 | 194.23M |
March 31, 2020 | -1.353M |
December 31, 2019 | 38.62M |
September 30, 2019 | -25.79M |
June 30, 2019 | 13.20M |
March 31, 2019 | 19.25M |
December 31, 2018 | 24.04M |
September 30, 2018 | 71.74M |
Date | Value |
---|---|
June 30, 2018 | 101.38M |
March 31, 2018 | 85.23M |
December 31, 2017 | 66.99M |
September 30, 2017 | 79.55M |
June 30, 2017 | 77.98M |
March 31, 2017 | 101.04M |
December 31, 2016 | 35.87M |
September 30, 2016 | 56.75M |
June 30, 2016 | 78.70M |
March 31, 2016 | 89.45M |
December 31, 2015 | 101.57M |
September 30, 2015 | 116.31M |
June 30, 2015 | 112.95M |
March 31, 2015 | 106.23M |
December 31, 2014 | 80.10M |
September 30, 2014 | 67.08M |
June 30, 2014 | 52.10M |
March 31, 2014 | 54.43M |
December 31, 2013 | 40.05M |
September 30, 2013 | 44.64M |
June 30, 2013 | 10.28M |
March 31, 2013 | 14.70M |
December 31, 2012 | 15.55M |
September 30, 2012 | 9.372M |
June 30, 2012 | 11.02M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-1.353M
Minimum
Mar 2020
519.35M
Maximum
Dec 2020
184.00M
Average
167.58M
Median
Shareholders Equity (Quarterly) Benchmarks
ADMA Biologics Inc | 231.89M |
Varex Imaging Corp | 535.10M |
Rhythm Pharmaceuticals Inc | 11.22M |
Inspire Medical Systems Inc | 696.56M |
Mirum Pharmaceuticals Inc | 232.02M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 586.01M |
Total Liabilities (Quarterly) | 393.86M |
Debt to Equity Ratio | 1.271 |
Current Ratio | 4.588 |
Net Debt Paydown Yield | -0.80% |